The primary effects of GLP-1 RA involve controlling blood glucose levels in individuals with T2DM by promoting glucose-dependent insulin release [67], inhibiting glucagon production, decreasing hepatic glucose output [68], improving insulin secretion, reducing the apoptosis of -cells, promoting the proliferation of -cells [69] and curbing weight gain [70]
Applesauce: Adds moisture to the cake without making it too heavy
Indian Journal of Experimental Biology, 49(11), 805816
Consistent lots for longitudinal work
Drug used to treat type 2 diabetes could reduce risk of severe COVID-19 outcomes, research suggests A type of drug used for the treatment of type 2 diabetes and obesity has been linked to a reduced risk of hospitalisation, respiratory complications, and death in people with COVID-19 who have type 2 diabetes